Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-...

por Pestalozzi, B. C., Francis, P., Quinaux, E., Dolci, S., Azambuja, E., Gelber, R. D., Viale, G., Balil, A., Andersson, M., Nordenskjöld, B., Gnant, M., Gutierrez, J., Láng, I., Crown, J. P. A., Piccart-Gebhart, M.
Publicado 2008

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

por Buisseret, L, Pommey, S, Allard, B, Garaud, S, Bergeron, M, Cousineau, I, Ameye, L, Bareche, Y, Paesmans, M, Crown, J P A, Di Leo, A, Loi, S, Piccart-Gebhart, M, Willard-Gallo, K, Sotiriou, C, Stagg, J
Publicado en Ann Oncol (2018)